<DOC>
	<DOCNO>NCT02084004</DOCNO>
	<brief_summary>The aim study assess beneficial effect Bifidobacterium Hydrochloride Berberine lower glucose patient type 2 diabetes mellitus detect potential mechanism .</brief_summary>
	<brief_title>Effects Berberine Hydrochloride Bifidobacterium Diabetes Mellitus Prevention Treatment</brief_title>
	<detailed_description>Gut microbiota maybe play important role patient type 2 diabetes mellitus ( T2DM ) . Berberine , usually use antibiotic drug , report potential glucose-lowering effect vitro vivo study . Bifidobacterium , familiar probiotic , modulate gut microbiota improve glucose lipid metabolism animal experiment . Therefore , aim study assess beneficial effect Bifidobacterium Hydrochloride Berberine lower glucose patient T2DM detect potential mechanism .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Informed consent obtain trialrelated activities； Male female 18 70 year age 19≤Body mass index ( BMI ) ≤30kg/m2 No participate clinical trial least 3 month Newly diagnose T2DM ( OGTT ) receive previous pharmacological treatment 7 % ≤HbA1c≤9 % Females childbearing period give birth control No severe disease heart , lung kidney Ability willingness adhere protocol include performance selfmonitored blood glucose ( SMBG ) profile accord protocol Subject likely comply Investigators instruction Type 2 1 diabetes mellitus receive previous pharmacological treatment Females childbearing potential pregnant，breastfeeding intend become pregnant use adequate contraceptive method Impaired liver function , define Aspartate aminotransferase（AST） Alanine transaminase ( ALT ) &gt; 2 time upper limit normal ( central laboratory ) Impaired renal function , define serumcreatinine≥133μmol/L Uncontrolled treated/untreated severe hypertension ( systolic blood pressure≥160mmHg /or diastolic blood pressure≥95mmHg ) Chronic gastrointestinal disease Cancer medical history cancer ( except basal cell skin cancer squamous cell skin cancer ) Any clinically significant disease disorder , Investigator 's opinion could interfere result trial Mental incapacity , psychiatric disorder , unwillingness language barrier preclude adequate understanding cooperation , include subject able read write Previous participation trial . Participation define randomize . Rescreening screen failure allow within limit recruitment period Known suspect hypersensitivity trial product related product Known suspected abuse alcohol , narcotic illicit drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Berberine Hydrochloride</keyword>
	<keyword>Bifidobacterium</keyword>
</DOC>